跳至主要内容
临床试验/EUCTR2013-004920-12-CZ
EUCTR2013-004920-12-CZ进行中(未招募)1 期

on-interventional Study in Allergic Patients Suffering from Grass Pollen Induced Rhinitis/Rhinoconjunctivitis with or without Asthma.Retrospective Assessment of the Efficacy of a Perennial Specific Immunotherapy on the Allergy Symptoms / Disease Activity during the Pollen Season - Depigoid Phleum - PRO 2013

ETI Pharma GmbH0 个研究点目标入组 275 人开始时间: 2013年12月11日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
275

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • · Written informed consent
  • · Allergic rhinitis/rhinoconjunctivitis with or without concomitant asthma due to grass pollen allergy
  • · Treatment with one of 4 concentrations of Depigoid Phleum (100, 1000, 5000 and 10000 DPP/ml) in the period from October 2012 until April 2013.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 266
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 9

排除标准

  • · Less than 4 applications of 0,5 ml of one of 4 concentrations of Depigoid Phleum (100, 1000, 5000 and 10000 DPP/ml) between October 2012 and April 2013

研究者

发起方
ETI Pharma GmbH

相似试验